| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 2 securities · passive | ||||||
|
Forte Biosciences, Inc.
13G/A
FBRX · 34962G208
|
2.4% |
1/9/2026
Event 1/8/2026
|
||||
| Oliveira Steven Michael | 2.4% | |||||
| Nemean Asset Management, LLC | 2.4% | |||||
|
Athira Pharma, Inc.
13G/A
ATHA · 04746L104
|
4.1% |
10/10/2025
Event 10/1/2025
|
||||
| Oliveira Steven Michael | 4.1% | |||||
| Nemean Asset Management, LLC | 3.8% | |||||
| South Ocean Capital LLC | 0.3% | |||||
| South Ocean Capital Management LLC | 0% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.